Literature DB >> 9223361

Adenosine as an antiarrhythmic agent.

S L Wilbur1, F E Marchlinski.   

Abstract

Adenosine produces acute inhibition of sinus node and atrioventricular (AV) nodal function. This profound but short lived electrophysiologic effect makes adenosine a suitable agent for treating supraventricular tachycardias (SVT) that incorporate the sinus node or AV node as part of the arrhythmia circuit, or for unmasking atrial tachyarrhythmias or ventricular pre-excitation. Its antiadrenergic properties also make it an effective agent for use with some unique atrial and ventricular tachycardias. Appropriate dosing and rapid bolusing with intravenous administration is required. Recognition of infrequent proarrhythmic risks and potential drug interactions with xanthine derivatives and dipyridamole should maximize its safe and effective use. This review will highlight adenosine's mechanism of action, administration, clinical indications, efficacy, and risks when used in tachyarrhythmic management.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223361     DOI: 10.1016/s0002-9149(97)00261-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

Review 1.  Mechanisms of antiarrhythmic drug actions and their clinical relevance for controlling disorders of cardiac rhythm.

Authors:  Uma Srivatsa; Nitin Wadhani; Bramah N Singh
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

2.  Evidence for both adenosine A1 and A2A receptors activating single vagal sensory C-fibres in guinea pig lungs.

Authors:  Benjamas Chuaychoo; Min-Goo Lee; Marian Kollarik; Rudolf Pullmann; Bradley J Undem
Journal:  J Physiol       Date:  2006-06-22       Impact factor: 5.182

Review 3.  Sinus arrest during adenosine stress testing in liver transplant recipients with graft failure: three case reports and a review of the literature.

Authors:  Kenneth N Giedd; Sabahat Bokhari; Teresa P Daniele; Lynne L Johnson
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

Review 4.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

5.  G protein-coupled receptors in cardiac biology: old and new receptors.

Authors:  Simon R Foster; Eugeni Roura; Peter Molenaar; Walter G Thomas
Journal:  Biophys Rev       Date:  2015-01-13

Review 6.  Cardiac GPCRs: GPCR signaling in healthy and failing hearts.

Authors:  Natasha C Salazar; Juhsien Chen; Howard A Rockman
Journal:  Biochim Biophys Acta       Date:  2007-02-20

7.  Adenosine myocardial protection: preliminary results of a phase II clinical trial.

Authors:  R M Mentzer; V Birjiniuk; S Khuri; J E Lowe; P S Rahko; R D Weisel; H A Wellons; M L Barker; R D Lasley
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

8.  Cardiac arrhythmias during pregnancy.

Authors:  Thomas Adam Burkart; Jamie Beth Conti
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-10

Review 9.  G-Protein-Coupled Receptors in Heart Disease.

Authors:  Jialu Wang; Clarice Gareri; Howard A Rockman
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

Review 10.  Arrhythmias in the pregnant patient: current concepts in evaluation and management.

Authors:  Jordana Kron; Jamie B Conti
Journal:  J Interv Card Electrophysiol       Date:  2007-08-09       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.